Plasmatic levels of IL-18, IP-10, and activated CD8+ T cells are potential biomarkers to identify HIV-1 elite controllers with a true functional cure profile

Côrtes, Fernanda H.; Paula, Hury H. S. de; Bello, Gonzalo; Ribeiro-Alves, Marcelo; Azevedo, Suwellen S. D. de; Caetano, Diogo G.; Teixeira, Sylvia L. M.; Hoagland, Brenda Regina de Siqueira; Grinsztejn, Beatriz; Santos, Valdiléa Gonçalves Veloso dos; Guimarães, Monick L.; Morgado, Mariza G..
Artículo en Inglés | ARCA | ID: arc-31245

Documentos relacionados

  1. Increased biomarkers of cardiovascular risk in HIV-1 viremic controllers and low persistent inflammation in elite controllers and art-suppressed individuals.
  2. Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency.
  3. Revisiting the recombinant history of HIV-1 group M with dynamic network community detection.
  4. Characteristics and mechanisms of latency-reversing agents in the activation of the human immunodeficiency virus 1 reservoir.
  5. Quantifying the HIV reservoir with dilution assays and deep viral sequencing.
  6. Characteristics and clinical significance of plasma IL-18, sCD14, and sCD163 levels in patients with HIV-1 infection.
  7. Validation of Promoters and Codon Optimization on CRISPR/Cas9-Engineered Jurkat Cells Stably Expressing αRep4E3 for Interfering with HIV-1 Replication.
  8. Harnessing Autophagy to Overcome Antigen-Specific T-Cell Dysfunction: Implication for People Living with HIV-1.
  9. Immunological approaches to HIV cure.
  10. Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV control.